» Articles » PMID: 22513726

Monte Carlo Study of the Potential Reduction in Out-of-field Dose Using a Patient-specific Aperture in Pencil Beam Scanning Proton Therapy

Overview
Journal Phys Med Biol
Publisher IOP Publishing
Date 2012 Apr 20
PMID 22513726
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

This study is aimed at identifying the potential benefits of using a patient-specific aperture in proton beam scanning. For this purpose, an accurate Monte Carlo model of the pencil beam scanning (PBS) proton therapy (PT) treatment head at Massachusetts General Hospital (MGH) was developed based on an existing model of the passive double-scattering (DS) system. The Monte Carlo code specifies the treatment head at MGH with sub-millimeter accuracy. The code was configured based on the results of experimental measurements performed at MGH. This model was then used to compare out-of-field doses in simulated DS treatments and PBS treatments. For the conditions explored, the penumbra in PBS is wider than in DS, leading to higher absorbed doses and equivalent doses adjacent to the primary field edge. For lateral distances greater than 10 cm from the field edge, the doses in PBS appear to be lower than those observed for DS. We found that placing a patient-specific aperture at nozzle exit during PBS treatments can potentially reduce doses lateral to the primary radiation field by over an order of magnitude. In conclusion, using a patient-specific aperture has the potential to further improve the normal tissue sparing capabilities of PBS.

Citing Articles

Utilizing collimated aperture with proton pencil beam scanning (PBS) for stereotactic radiotherapy.

Chou C, Tsai T, Huang H, Wang C, Lee S, Hsu S J Appl Clin Med Phys. 2024; 25(7):e14362.

PMID: 38669175 PMC: 11244669. DOI: 10.1002/acm2.14362.


Modelling small block aperture in an in-house developed GPU-accelerated Monte Carlo-based dose engine for pencil beam scanning proton therapy.

Feng H, Holmes J, Vora S, Stoker J, Bues M, Wong W Phys Med Biol. 2023; 69(3).

PMID: 37944480 PMC: 11009986. DOI: 10.1088/1361-6560/ad0b64.


Measurements of fetal dose with Mevion S250i proton therapy system with HYPERSCAN.

Hopfensperger K, Li X, Paxton A, Sarkar V, Su F, Price R J Appl Clin Med Phys. 2023; 24(5):e13957.

PMID: 37043346 PMC: 10161065. DOI: 10.1002/acm2.13957.


Simulation study using the spots deletion technique in spot scanning proton beam therapy for prostate cancers.

Fukumitsu N, Hayakawa T, Yamashita T, Mima M, Demizu Y, Suzuki T Mol Clin Oncol. 2021; 16(1):25.

PMID: 34909203 PMC: 8655742. DOI: 10.3892/mco.2021.2458.


Monte Carlo methods for device simulations in radiation therapy.

Park H, Paganetti H, Schuemann J, Jia X, Min C Phys Med Biol. 2021; 66(18).

PMID: 34384063 PMC: 8996747. DOI: 10.1088/1361-6560/ac1d1f.


References
1.
Kooy H, Clasie B, Lu H, Madden T, Bentefour H, Depauw N . A case study in proton pencil-beam scanning delivery. Int J Radiat Oncol Biol Phys. 2010; 76(2):624-30. DOI: 10.1016/j.ijrobp.2009.06.065. View

2.
Jarlskog C, Paganetti H . Sensitivity of different dose scoring methods on organ-specific neutron dose calculations in proton therapy. Phys Med Biol. 2008; 53(17):4523-32. DOI: 10.1088/0031-9155/53/17/004. View

3.
Low D, Harms W, Mutic S, Purdy J . A technique for the quantitative evaluation of dose distributions. Med Phys. 1998; 25(5):656-61. DOI: 10.1118/1.598248. View

4.
Paganetti H . Monte Carlo calculations for absolute dosimetry to determine machine outputs for proton therapy fields. Phys Med Biol. 2006; 51(11):2801-12. PMC: 2292643. DOI: 10.1088/0031-9155/51/11/008. View

5.
. Relative biological effectiveness (RBE), quality factor (Q), and radiation weighting factor (w(R)). A report of the International Commission on Radiological Protection. Ann ICRP. 2003; 33(4):1-117. DOI: 10.1016/s0146-6453(03)00024-1. View